440 related articles for article (PubMed ID: 33450205)
1. Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancer.
Bowling EA; Wang JH; Gong F; Wu W; Neill NJ; Kim IS; Tyagi S; Orellana M; Kurley SJ; Dominguez-Vidaña R; Chung HC; Hsu TY; Dubrulle J; Saltzman AB; Li H; Meena JK; Canlas GM; Chamakuri S; Singh S; Simon LM; Olson CM; Dobrolecki LE; Lewis MT; Zhang B; Golding I; Rosen JM; Young DW; Malovannaya A; Stossi F; Miles G; Ellis MJ; Yu L; Buonamici S; Lin CY; Karlin KL; Zhang XH; Westbrook TF
Cell; 2021 Jan; 184(2):384-403.e21. PubMed ID: 33450205
[TBL] [Abstract][Full Text] [Related]
2. The spliceosome is a therapeutic vulnerability in MYC-driven cancer.
Hsu TY; Simon LM; Neill NJ; Marcotte R; Sayad A; Bland CS; Echeverria GV; Sun T; Kurley SJ; Tyagi S; Karlin KL; Dominguez-Vidaña R; Hartman JD; Renwick A; Scorsone K; Bernardi RJ; Skinner SO; Jain A; Orellana M; Lagisetti C; Golding I; Jung SY; Neilson JR; Zhang XH; Cooper TA; Webb TR; Neel BG; Shaw CA; Westbrook TF
Nature; 2015 Sep; 525(7569):384-8. PubMed ID: 26331541
[TBL] [Abstract][Full Text] [Related]
3. Spliceosome-Targeted Therapies Induce dsRNA Responses.
Ishak CA; Loo Yau H; De Carvalho DD
Immunity; 2021 Jan; 54(1):11-13. PubMed ID: 33440135
[TBL] [Abstract][Full Text] [Related]
4. Emerging roles of spliceosome in cancer and immunity.
Yang H; Beutler B; Zhang D
Protein Cell; 2022 Aug; 13(8):559-579. PubMed ID: 34196950
[TBL] [Abstract][Full Text] [Related]
5. Interplay between A-to-I Editing and Splicing of RNA: A Potential Point of Application for Cancer Therapy.
Goncharov AO; Shender VO; Kuznetsova KG; Kliuchnikova AA; Moshkovskii SA
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563631
[TBL] [Abstract][Full Text] [Related]
6. RNA splicing, cell signaling, and response to therapies.
Abou Faycal C; Gazzeri S; Eymin B
Curr Opin Oncol; 2016 Jan; 28(1):58-64. PubMed ID: 26575690
[TBL] [Abstract][Full Text] [Related]
7. BRD4 modulates vulnerability of triple-negative breast cancer to targeting of integrin-dependent signaling pathways.
Zhang Y; Xu B; Shi J; Li J; Lu X; Xu L; Yang H; Hamad N; Wang C; Napier D; He S; Liu C; Liu Z; Qian H; Chen L; Wei X; Zheng X; Huang JA; Thibault O; Craven R; Wei D; Pan Y; Zhou BP; Wu Y; Yang XH
Cell Oncol (Dordr); 2020 Dec; 43(6):1049-1066. PubMed ID: 33006750
[TBL] [Abstract][Full Text] [Related]
8. MYC suppresses STING-dependent innate immunity by transcriptionally upregulating DNMT1 in triple-negative breast cancer.
Wu SY; Xiao Y; Wei JL; Xu XE; Jin X; Hu X; Li DQ; Jiang YZ; Shao ZM
J Immunother Cancer; 2021 Jul; 9(7):. PubMed ID: 34321275
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer.
Cieśla M; Ngoc PCT; Cordero E; Martinez ÁS; Morsing M; Muthukumar S; Beneventi G; Madej M; Munita R; Jönsson T; Lövgren K; Ebbesson A; Nodin B; Hedenfalk I; Jirström K; Vallon-Christersson J; Honeth G; Staaf J; Incarnato D; Pietras K; Bosch A; Bellodi C
Mol Cell; 2021 Apr; 81(7):1453-1468.e12. PubMed ID: 33662273
[TBL] [Abstract][Full Text] [Related]
10. Homologous recombination deficiency and host anti-tumor immunity in triple-negative breast cancer.
Telli ML; Stover DG; Loi S; Aparicio S; Carey LA; Domchek SM; Newman L; Sledge GW; Winer EP
Breast Cancer Res Treat; 2018 Aug; 171(1):21-31. PubMed ID: 29736741
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency.
Mehdipour P; Marhon SA; Ettayebi I; Chakravarthy A; Hosseini A; Wang Y; de Castro FA; Loo Yau H; Ishak C; Abelson S; O'Brien CA; De Carvalho DD
Nature; 2020 Dec; 588(7836):169-173. PubMed ID: 33087935
[TBL] [Abstract][Full Text] [Related]
12. Phosphatidylserine-targeting antibodies augment the anti-tumorigenic activity of anti-PD-1 therapy by enhancing immune activation and downregulating pro-oncogenic factors induced by T-cell checkpoint inhibition in murine triple-negative breast cancers.
Gray MJ; Gong J; Hatch MM; Nguyen V; Hughes CC; Hutchins JT; Freimark BD
Breast Cancer Res; 2016 May; 18(1):50. PubMed ID: 27169467
[TBL] [Abstract][Full Text] [Related]
13. The Role and Mechanism of CRT0066101 as an Effective Drug for Treatment of Triple-Negative Breast Cancer.
Liu Y; Wang Y; Yu S; Zhou Y; Ma X; Su Q; An L; Wang F; Shi A; Zhang J; Chen L
Cell Physiol Biochem; 2019; 52(3):382-396. PubMed ID: 30845378
[TBL] [Abstract][Full Text] [Related]
14. Folate metabolism negatively regulates OAS-mediated antiviral innate immunity via ADAR3/endogenous dsRNA pathway.
Wu J; You Q; Lyu R; Qian Y; Tao H; Zhang F; Cai Y; Jiang N; Zheng N; Chen D; Wu Z
Metabolism; 2023 Jun; 143():155526. PubMed ID: 36822494
[TBL] [Abstract][Full Text] [Related]
15. Inhibition effect of exosomes-mediated Let-7a on the development and metastasis of triple negative breast cancer by down-regulating the expression of c-Myc.
Du J; Fan JJ; Dong C; Li HT; Ma BL
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5301-5314. PubMed ID: 31298382
[TBL] [Abstract][Full Text] [Related]
16. Classification of triple-negative breast cancers based on Immunogenomic profiling.
He Y; Jiang Z; Chen C; Wang X
J Exp Clin Cancer Res; 2018 Dec; 37(1):327. PubMed ID: 30594216
[TBL] [Abstract][Full Text] [Related]
17. Distinct Minor Splicing Patterns across Cancers.
Levesque L; Salazar N; Roy SW
Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205431
[TBL] [Abstract][Full Text] [Related]
18. Potential effect of spliceosome inhibition in small cell lung cancer irrespective of the MYC status.
Suda K; Rozeboom L; Yu H; Ellison K; Rivard CJ; Mitsudomi T; Hirsch FR
PLoS One; 2017; 12(2):e0172209. PubMed ID: 28192473
[TBL] [Abstract][Full Text] [Related]
19. Splicing segregation: the minor spliceosome acts outside the nucleus and controls cell proliferation.
König H; Matter N; Bader R; Thiele W; Müller F
Cell; 2007 Nov; 131(4):718-29. PubMed ID: 18022366
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of antiviral innate immunity by birnavirus VP3 protein via blockage of viral double-stranded RNA binding to the host cytoplasmic RNA detector MDA5.
Ye C; Jia L; Sun Y; Hu B; Wang L; Lu X; Zhou J
J Virol; 2014 Oct; 88(19):11154-65. PubMed ID: 25031338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
